AMGN

Beyond's analysis on AMGN

• 2026-09-13 — Amgen shares drop 5% amid doubts over its Lp(a) drug bet

Recent news mentioning AMGN

• 2026-09-17 — A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) Too
• 2026-09-17 — Amgen Stock Fell 10% in a Day on a Drug It Doesn’t Own. Is It Time to Buy AMGN?
• 2026-09-13 — Amgen (AMGN) Fell 5% on a Drug That Isn’t Even Its Own. Here’s the Lp(a) Bet Now in Question.
• 2026-09-12 — Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
• 2026-09-09 — Could AstraZeneca (AZN)’s Stronger Growth Make it a Better Bet than Amgen (AMGN)?

Appears alongside

• Eli Lilly
• LLY
• Novartis
• AstraZeneca

Browse the full archive →